Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epileptic seizures in diffuse low-grade gliomas in adults.
Pallud J, Audureau E, Blonski M, Sanai N, Bauchet L, Fontaine D, Mandonnet E, Dezamis E, Psimaras D, Guyotat J, Peruzzi P, Page P, Gal B, Párraga E, Baron MH, Vlaicu M, Guillevin R, Devaux B, Duffau H, Taillandier L, Capelle L, Huberfeld G. Pallud J, et al. Among authors: baron mh. Brain. 2014 Feb;137(Pt 2):449-62. doi: 10.1093/brain/awt345. Epub 2013 Dec 27. Brain. 2014. PMID: 24374407
Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.
Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M, Guyotat J, Guillevin R, Frenay M, Taillibert S, Colin P, Rigau V, Vandenbos F, Pinelli C, Duffau H; French Réseau d'Étude des Gliomes. Capelle L, et al. Among authors: baron mh. J Neurosurg. 2013 Jun;118(6):1157-68. doi: 10.3171/2013.1.JNS121. Epub 2013 Mar 15. J Neurosurg. 2013. PMID: 23495881
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.
Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R, Bauchet L, Peruzzi P, Laigle-Donadey F, Kujas M, Guyotat J, Baron MH, Mokhtari K, Duffau H. Pallud J, et al. Among authors: baron mh. Neuro Oncol. 2009 Apr;11(2):176-82. doi: 10.1215/15228517-2008-066. Epub 2008 Aug 12. Neuro Oncol. 2009. PMID: 18697954 Free PMC article.
Natural history of incidental World Health Organization grade II gliomas.
Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L. Pallud J, et al. Among authors: baron mh. Ann Neurol. 2010 Nov;68(5):727-33. doi: 10.1002/ana.22106. Ann Neurol. 2010. PMID: 21031584
Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.
Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, Bauchet L, Peruzzi P, Frénay M, Colin P, Guillevin R, Bernier V, Baron MH, Guyotat J, Duffau H, Taillandier L, Capelle L. Pallud J, et al. Among authors: baron mh. Neuro Oncol. 2013 May;15(5):595-606. doi: 10.1093/neuonc/nos331. Epub 2013 Feb 7. Neuro Oncol. 2013. PMID: 23393207 Free PMC article.
Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma.
Still MEH, Roux A, Huberfeld G, Bauchet L, Baron MH, Fontaine D, Blonski M, Mandonnet E, Guillevin R, Guyotat J, Taillandier L, Capelle L, Duffau H, Pallud J. Still MEH, et al. Among authors: baron mh. Neurosurgery. 2019 Aug 1;85(2):E332-E340. doi: 10.1093/neuros/nyy481. Neurosurgery. 2019. PMID: 30395304
Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.
Blonski M, Pallud J, Gozé C, Mandonnet E, Rigau V, Bauchet L, Fabbro M, Beauchesne P, Baron MH, Fontaine D, Peruzzi P, Darlix A, Duffau H, Taillandier L. Blonski M, et al. Among authors: baron mh. J Neurooncol. 2013 Jun;113(2):267-75. doi: 10.1007/s11060-013-1106-6. Epub 2013 Mar 12. J Neurooncol. 2013. PMID: 23479036
Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?
Mandonnet E, Wager M, Almairac F, Baron MH, Blonski M, Freyschlag CF, Barone F, Fontaine D, Pallud J, Hegi M, Viegas C, Zetterling M, Spena G, Goodden J, Rutten GJ, Taillandier L, Foroglu N, Darlix A, Skrap M, Martino J, von Campe G, Madadaki C, Gayat E, de Witt Hamer P, Gil Robles S, Sarubbo S, Santarius T, Bello L, Forster MT, Duffau H. Mandonnet E, et al. Among authors: baron mh. Neurooncol Pract. 2017 Dec;4(4):241-247. doi: 10.1093/nop/npw031. Epub 2017 Jan 17. Neurooncol Pract. 2017. PMID: 31386020 Free PMC article.
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.
Darlix A, Mandonnet E, Freyschlag CF, Pinggera D, Forster MT, Voss M, Steinbach J, Loughrey C, Goodden J, Banna G, Di Blasi C, Foroglou N, Hottinger AF, Baron MH, Pallud J, Duffau H, Rutten GJ, Almairac F, Fontaine D, Taillandier L, Pessanha Viegas C, Albuquerque L, von Campe G, Urbanic-Purkart T, Blonski M. Darlix A, et al. Among authors: baron mh. Neurooncol Pract. 2019 Jul;6(4):264-273. doi: 10.1093/nop/npy051. Epub 2018 Dec 13. Neurooncol Pract. 2019. PMID: 31386080 Free PMC article.
128 results